United-Guardian
About: United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
Employees: 25
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
6% more funds holding
Funds holding: 31 [Q3] → 33 (+2) [Q4]
0.53% more ownership
Funds ownership: 21.91% [Q3] → 22.44% (+0.53%) [Q4]
38% less capital invested
Capital invested by funds: $16M [Q3] → $9.88M (-$6.09M) [Q4]
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Research analyst outlook
We haven’t received any recent analyst ratings for UG.
Financial journalist opinion
